SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-014822
Filing Date
2024-04-16
Accepted
2024-04-16 16:11:03
Documents
102
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1751846
2 ex31-1.htm EX-31.1 12479
3 ex31-2.htm EX-31.2 12443
4 ex32-1.htm EX-32.1 4356
5 ex32-2.htm EX-32.2 4516
6 form10-k_001.jpg GRAPHIC 1713
  Complete submission text file 0001493152-24-014822.txt   9015366

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE adxs-20231231.xsd EX-101.SCH 84498
8 XBRL CALCULATION FILE adxs-20231231_cal.xml EX-101.CAL 95398
9 XBRL DEFINITION FILE adxs-20231231_def.xml EX-101.DEF 257308
10 XBRL LABEL FILE adxs-20231231_lab.xml EX-101.LAB 583677
11 XBRL PRESENTATION FILE adxs-20231231_pre.xml EX-101.PRE 433549
105 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1544710
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 24847934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)